bf/NASDAQ:CORT_icon.jpeg

COM:CORCEPT

Corcept Therapeutics

  • Stock

USD

Last Close

55.92

22/11 21:00

Market Cap

3.19B

Beta: -

Volume Today

648.55K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
10.36M
-
26.55M
156.36%
50.29M
89.39%
81.32M
61.72%
159.20M
95.77%
251.25M
57.82%
306.49M
21.99%
353.87M
15.46%
365.98M
3.42%
401.86M
9.80%
482.38M
20.04%
cost of revenue
143K
-
882K
516.78%
1.36M
54.31%
2.06M
51.21%
3.55M
72.69%
5.21M
46.74%
5.50M
5.54%
5.58M
1.42%
5.28M
5.39%
5.38M
1.97%
6.48M
20.35%
gross profit
10.21M
-
25.67M
151.31%
48.92M
90.60%
79.26M
62.01%
155.65M
96.37%
246.03M
58.07%
300.98M
22.33%
348.29M
15.72%
360.70M
3.56%
396.47M
9.92%
475.89M
20.03%
selling and marketing expenses
general and administrative expenses
selling general and administrative expenses
31.24M
-
34.92M
11.77%
36.95M
5.82%
45.24M
22.44%
62.42M
37.97%
81.29M
30.24%
100.36M
23.46%
105.33M
4.95%
122.36M
16.17%
152.85M
24.92%
184.26M
20.55%
research and development expenses
20.47M
-
18.37M
10.25%
15.42M
16.07%
23.84M
54.64%
40.38M
69.33%
75.25M
86.37%
89.02M
18.30%
114.76M
28.92%
113.86M
0.78%
130.99M
15.04%
184.35M
40.74%
other expenses
cost and expenses
51.85M
-
54.17M
4.47%
53.73M
0.81%
71.14M
32.41%
106.35M
49.48%
161.75M
52.10%
194.88M
20.48%
225.67M
15.80%
241.50M
7.01%
289.22M
19.76%
375.09M
29.69%
operating expenses
51.71M
-
53.29M
3.05%
52.37M
1.73%
69.08M
31.92%
102.79M
48.79%
156.54M
52.28%
189.38M
20.98%
220.09M
16.22%
236.22M
7.33%
283.84M
20.16%
368.61M
29.87%
interest expense
4.51M
-
3.76M
16.63%
2.96M
21.23%
2.04M
31.23%
49K
97.60%
2.66M
5,322.45%
5.07M
90.82%
3.56M
-
ebitda
-41.42M
-
-27.48M
33.66%
-3.29M
88.03%
10.27M
412.23%
52.85M
414.85%
89.50M
69.32%
111.61M
24.71%
128.20M
14.87%
124.48M
2.91%
112.63M
9.51%
109.64M
2.65%
operating income
-41.50M
-
-27.62M
33.44%
-3.44M
87.53%
10.18M
395.64%
52.85M
419.26%
89.50M
69.32%
111.61M
24.71%
128.20M
14.87%
124.48M
2.91%
112.63M
9.51%
107.28M
4.75%
depreciation and amortization
74K
-
141K
90.54%
155K
9.93%
87K
43.87%
106K
21.84%
236K
122.64%
2.17M
819.92%
2.24M
3.04%
3.07M
37.10%
2.97M
3.20%
2.36M
20.44%
total other income expenses net
-4.51M
-
-3.76M
16.63%
-2.96M
21.23%
-2.04M
31.23%
-49K
97.60%
2.66M
5,522.45%
5.07M
90.82%
3.40M
32.94%
529K
84.44%
3.56M
572.40%
17.27M
385.66%
income before tax
-46.01M
-
-31.38M
31.79%
-6.41M
79.58%
8.14M
227.03%
52.81M
548.72%
92.15M
74.51%
116.68M
26.61%
131.60M
12.79%
125.01M
5.01%
116.19M
7.05%
124.56M
7.20%
income tax expense
-76.32M
-
16.74M
121.94%
22.50M
34.35%
25.59M
13.76%
12.49M
51.18%
14.77M
18.24%
18.42M
24.67%
net income
-46.01M
-
-31.38M
31.79%
-6.41M
79.58%
8.14M
227.03%
129.12M
1,486.27%
75.41M
41.60%
94.18M
24.89%
106.01M
12.56%
112.51M
6.13%
101.42M
9.86%
106.14M
4.66%
weighted average shs out
99.82M
-
100.98M
1.16%
106.88M
5.85%
110.57M
3.45%
113.53M
2.68%
115.34M
1.60%
114.35M
0.86%
115.41M
0.93%
115.65M
0.21%
106.79M
7.67%
111.74M
4.64%
weighted average shs out dil
99.82M
-
100.98M
1.16%
106.88M
5.85%
116.14M
8.66%
124.52M
7.21%
126.69M
1.75%
122.57M
3.25%
124.19M
1.33%
125.96M
1.42%
115.97M
7.94%
111.74M
3.64%
eps
-0.46
-
-0.31
32.61%
-0.06
80.65%
0.07
216.67%
1.14
1,528.57%
0.65
42.98%
0.82
26.15%
0.92
12.20%
0.97
5.43%
0.95
2.06%
1.02
7.37%
epsdiluted
-0.46
-
-0.31
32.61%
-0.06
80.65%
0.07
216.67%
1.04
1,385.71%
0.60
42.31%
0.77
28.33%
0.85
10.39%
0.89
4.71%
0.87
2.25%
0.94
8.05%

All numbers in USD (except ratios and percentages)